Baidu
map

心血管

订阅

MedSci主页 / 所有栏目 / 心血管

中文版2012ESC 瓣膜性心脏病管理指南

2012-10-26 首都医科大学附属北京友谊医院 赵树海 李卫萍 郭春燕 李虹伟 EACTS

ESC中文版指南瓣膜性心脏病管理
关注

指南的重点在于成人和青少年VHD的处理，不涉及心内膜炎以及成人和青少年的先天性心脏病。 中文版2012ESC+瓣膜性心脏病处理指南.pdf

指南的重点在于成人和青少年VHD的处理，不涉及心内膜炎以及成人和青少年的先天性心脏病。

中文版2012ESC+瓣膜性心脏病处理指南.pdf

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1936250, encodeId=a61219362506e, content=<a href='/topic/show?id=daa1e60387b' target=_blank style='color:#2F92EE;'>#管理指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76038, encryptionId=daa1e60387b, topicName=管理指南)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUEDhSibBFt8TicgFCCSBtW10SxVJicDpibTCucns8L1YaiaKpibWOkv8hYpJ0LeTVUH1Ab4sfica9bxiccA/132, createdBy=dd282500126, createdName=ms3830150583600765, createdTime=Thu Jun 27 03:00:00 CST 2013, time=2013-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2019569, encodeId=5ea8201956910, content=<a href='/topic/show?id=f76968e7854' target=_blank style='color:#2F92EE;'>#瓣膜性心脏病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68778, encryptionId=f76968e7854, topicName=瓣膜性心脏病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Fri Mar 22 23:00:00 CST 2013, time=2013-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1798226, encodeId=61f41e982265b, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68777, encryptionId=77d768e77e2, topicName=瓣膜性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cdcd18, createdName=bshuang, createdTime=Fri Oct 26 13:00:00 CST 2012, time=2012-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1583424, encodeId=91a6158342438, content=<a href='/topic/show?id=508d68e698c' target=_blank style='color:#2F92EE;'>#瓣膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68769, encryptionId=508d68e698c, topicName=瓣膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58dc16986228, createdName=12498e5fm17(暂无昵称), createdTime=Sat Oct 27 15:00:00 CST 2012, time=2012-10-27, status=1, ipAttribution=)]
    2013-06-27 ms3830150583600765

    #管理指南#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1936250, encodeId=a61219362506e, content=<a href='/topic/show?id=daa1e60387b' target=_blank style='color:#2F92EE;'>#管理指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76038, encryptionId=daa1e60387b, topicName=管理指南)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUEDhSibBFt8TicgFCCSBtW10SxVJicDpibTCucns8L1YaiaKpibWOkv8hYpJ0LeTVUH1Ab4sfica9bxiccA/132, createdBy=dd282500126, createdName=ms3830150583600765, createdTime=Thu Jun 27 03:00:00 CST 2013, time=2013-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2019569, encodeId=5ea8201956910, content=<a href='/topic/show?id=f76968e7854' target=_blank style='color:#2F92EE;'>#瓣膜性心脏病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68778, encryptionId=f76968e7854, topicName=瓣膜性心脏病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Fri Mar 22 23:00:00 CST 2013, time=2013-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1798226, encodeId=61f41e982265b, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68777, encryptionId=77d768e77e2, topicName=瓣膜性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cdcd18, createdName=bshuang, createdTime=Fri Oct 26 13:00:00 CST 2012, time=2012-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1583424, encodeId=91a6158342438, content=<a href='/topic/show?id=508d68e698c' target=_blank style='color:#2F92EE;'>#瓣膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68769, encryptionId=508d68e698c, topicName=瓣膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58dc16986228, createdName=12498e5fm17(暂无昵称), createdTime=Sat Oct 27 15:00:00 CST 2012, time=2012-10-27, status=1, ipAttribution=)]
    2013-03-22 yanjie6253_56072842

    #瓣膜性心脏病#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1936250, encodeId=a61219362506e, content=<a href='/topic/show?id=daa1e60387b' target=_blank style='color:#2F92EE;'>#管理指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76038, encryptionId=daa1e60387b, topicName=管理指南)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUEDhSibBFt8TicgFCCSBtW10SxVJicDpibTCucns8L1YaiaKpibWOkv8hYpJ0LeTVUH1Ab4sfica9bxiccA/132, createdBy=dd282500126, createdName=ms3830150583600765, createdTime=Thu Jun 27 03:00:00 CST 2013, time=2013-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2019569, encodeId=5ea8201956910, content=<a href='/topic/show?id=f76968e7854' target=_blank style='color:#2F92EE;'>#瓣膜性心脏病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68778, encryptionId=f76968e7854, topicName=瓣膜性心脏病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Fri Mar 22 23:00:00 CST 2013, time=2013-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1798226, encodeId=61f41e982265b, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68777, encryptionId=77d768e77e2, topicName=瓣膜性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cdcd18, createdName=bshuang, createdTime=Fri Oct 26 13:00:00 CST 2012, time=2012-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1583424, encodeId=91a6158342438, content=<a href='/topic/show?id=508d68e698c' target=_blank style='color:#2F92EE;'>#瓣膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68769, encryptionId=508d68e698c, topicName=瓣膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58dc16986228, createdName=12498e5fm17(暂无昵称), createdTime=Sat Oct 27 15:00:00 CST 2012, time=2012-10-27, status=1, ipAttribution=)]
    2012-10-26 bshuang

    #瓣膜性#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1936250, encodeId=a61219362506e, content=<a href='/topic/show?id=daa1e60387b' target=_blank style='color:#2F92EE;'>#管理指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76038, encryptionId=daa1e60387b, topicName=管理指南)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUEDhSibBFt8TicgFCCSBtW10SxVJicDpibTCucns8L1YaiaKpibWOkv8hYpJ0LeTVUH1Ab4sfica9bxiccA/132, createdBy=dd282500126, createdName=ms3830150583600765, createdTime=Thu Jun 27 03:00:00 CST 2013, time=2013-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2019569, encodeId=5ea8201956910, content=<a href='/topic/show?id=f76968e7854' target=_blank style='color:#2F92EE;'>#瓣膜性心脏病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68778, encryptionId=f76968e7854, topicName=瓣膜性心脏病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Fri Mar 22 23:00:00 CST 2013, time=2013-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1798226, encodeId=61f41e982265b, content=<a href='/topic/show?id=77d768e77e2' target=_blank style='color:#2F92EE;'>#瓣膜性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68777, encryptionId=77d768e77e2, topicName=瓣膜性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cdcd18, createdName=bshuang, createdTime=Fri Oct 26 13:00:00 CST 2012, time=2012-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1583424, encodeId=91a6158342438, content=<a href='/topic/show?id=508d68e698c' target=_blank style='color:#2F92EE;'>#瓣膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68769, encryptionId=508d68e698c, topicName=瓣膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58dc16986228, createdName=12498e5fm17(暂无昵称), createdTime=Sat Oct 27 15:00:00 CST 2012, time=2012-10-27, status=1, ipAttribution=)]
    2012-10-27 12498e5fm17(暂无昵称)

    #瓣膜#

    0

相关资讯

ESC2009肺高血压诊断治疗指南

ESC2009肺高血压诊断治疗指南.doc

ESC心血管疾病预防新指南公布

　　 　　2012ESC+临床实践指南：心血管疾病的预防.pdf     欧洲心脏病学会（ESC）于5月3日公布了心血管疾病预防新指南，并重点强调了心血管疾病的终生预防以及心脏健康生活方式和行为的实施。该指南在《欧洲心脏杂志》（Eur Heart J）发表并在欧洲预防会议2012（EuroPrevent2012）报告。 　　为便于临床实施，新

黄峻教授评ESC心衰器械治疗指南

　　 2010年欧洲心脏病年会（ESC2010）公布的指南放宽了心衰器械治疗适应征，经过治疗后NYHA II级的患者也是适应证，可以安装3腔起搏器。使得心衰器械治疗成为了心衰的预防策略，使更多患者获益。器械治疗一方面可以延缓NYHA II级患者发展为III级，预防心衰症状加重；另外，也能够改善患者预后。 　　这是心衰治疗中一项具有里程碑意义的举措。过去20年，心衰治疗药物不断取得进展

Baidu
map
Baidu
map
Baidu
map